Skip to main content
Premium Trial:

Request an Annual Quote

Swift Biosciences RNA Library Kits

Swift Biosciences has launched its RNA Library Kits. With patented Adaptase technology, the kits allow direct conversion of first-strand complementary DNA, reverse transcribed from RNA, into libraries for Illumina sequencing.

The firm is offering two kits: the Swift RNA Library Kit, which supports a broad input range from as little as 10 nanograms of total RNA or 100 picograms of poly(A)-enriched messenger RNA or ribosomal RNA-depleted RNA, and the Swift Rapid RNA Library Kit, which is faster and lower-priced. Both kits are available in 24- or 96-reaction kits.

The products include an RNA fragmentation module, a reverse transcription module, library prep reagents, polymerase, and several indexing primer kit options for single, combinatorial, and unique dual indexing.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.